1. Home
  2. IPAR vs BEAM Comparison

IPAR vs BEAM Comparison

Compare IPAR & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inter Parfums Inc.

IPAR

Inter Parfums Inc.

HOLD

Current Price

$92.58

Market Cap

3.1B

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$27.73

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPAR
BEAM
Founded
1982
2017
Country
United States
United States
Employees
647
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.7B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
IPAR
BEAM
Price
$92.58
$27.73
Analyst Decision
Strong Buy
Buy
Analyst Count
6
16
Target Price
$125.50
$49.13
AVG Volume (30 Days)
225.3K
1.6M
Earning Date
05-11-2026
05-15-2026
Dividend Yield
3.35%
N/A
EPS Growth
7.79
82.31
EPS
4.36
N/A
Revenue
$1,317,700,000.00
$24,000.00
Revenue This Year
$4.60
N/A
Revenue Next Year
$9.25
$35.80
P/E Ratio
$21.95
N/A
Revenue Growth
21.26
33.33
52 Week Low
$77.21
$13.53
52 Week High
$142.50
$36.44

Technical Indicators

Market Signals
Indicator
IPAR
BEAM
Relative Strength Index (RSI) 37.07 47.80
Support Level $92.30 $25.89
Resistance Level $101.50 $29.06
Average True Range (ATR) 3.46 1.91
MACD -1.34 0.00
Stochastic Oscillator 13.80 23.62

Price Performance

Historical Comparison
IPAR
BEAM

About IPAR Inter Parfums Inc.

Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: